John Barnard

John Barnard

Fundador en
Barnard Associates, Inc.
.
Health Technology
Finance
Consumer Services

Perfil

Dr. Brennan was previously a General Partner at Oxford Bioscience Partners.
Prior to that, he was President and Chief Executive Officer of Gene Logic (NASDAQ: GLGC).
During Dr. Brennan’s time at Gene Logic, he built the company from a start-up to a public company that achieved a market capitalization of over $5 billion.
He raised three rounds of venture capital and led Gene Logic to an IPO in November, 1997 and a large secondary public offering in January, 2000.
Dr. Brennan’s previous experience includes six years in the biopharmaceutical industry, where he has served as Vice President, Business Development for Boehringer Mannheim Therapeutics.
Dr. Brennan received a B.S.
in Biochemistry, a Ph.D.
in neurobiology and a M.D.
from the University of Witwatersrand, Johannesburg, South Africa.

Cargos activos de John Barnard

EmpresasCargoInicio
Director de Inversiones -
Fundador 14/08/2009
Director/Miembro de la Junta -
Director/Miembro de la Junta 16/08/2010
Fundador 01/01/2003
Barnard Life Sciences LLC
Fundador 01/01/2001
Director/Miembro de la Junta -

Antiguos cargos conocidos de John Barnard.

EmpresasCargoFin
Director/Miembro de la Junta 03/11/2008
Inversor de Capital Privado 01/01/2003
░░░░ ░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ -
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ver el detalle de la experiencia de John Barnard.

Formación de John Barnard.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

44

Relaciones de 1er grado

15

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas15

Health Technology

Finance

Health Technology

Technology Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Finance

Barnard Life Sciences LLC

Finance

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN